Baudax Bio Inc

NASDAQ:BXRX   3:20:52 PM EDT
0.15
+0.01 (+7.32%)
Earnings Announcements

Baudax Bio Reports Q3 2022 Results

Published: 11/08/2022 22:43 GMT
Baudax Bio Inc (BXRX) - Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights.
Baudax Bio Inc Q3 Loss per Share $2.47.
Baudax Bio Inc Qtrly Net Product Revenue Related to Sales of Anjeso in U.S. $0.2 Million Versus $0.3 Million.
Revenue is expected to be $0.22 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0.23 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.